International research indicates giving infants nirsevimab would cause sharp drop in rates of respiratory syncytial virus infection
A vaccine could reduce by 80% the numbers of babies and young children admitted to hospital with respiratory syncytial virus (RSV), a “groundbreaking” study has found.
The study, published in the peer-reviewed New England Journal of Medicine, involved 8,058 healthy babies aged up to 12 months from the UK, France and Germany, who were approaching their first RSV season.
About Author
More Stories
Researchers create AI-based tool that restores age-damaged artworks in hours
Australia has ‘no alternative’ but to embrace AI and seek to be a world leader in the field, industry and science minister says
European journalists targeted with Paragon Solutions spyware, say researchers